Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL
- Status
- COMPLETED
- Phase
- PHASE1
Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Observational Study of CLL/SLL Treatment and Ibrutinib Treatment of CLL/SLL in Routine Clinical Practice
- Status
- UNKNOWN
- Phase
- N/A
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment
- Status
- UNKNOWN
- Phase
- PHASE2
ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Understanding Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- N/A
BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Participants With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib, Acalabrutinib or Venetoclax
- Status
- TERMINATED
- Phase
- PHASE2
Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE3
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Status
- RECRUITING
- Phase
- PHASE2
A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- N/A
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2